Ch. 4 Pharm: Sedative-Hypnotics & ADHD Agents Flashcards

1
Q

Sedative-Hypnotics: Background Assessment data = indications

A

-Indications: short term management of various anxiety states and treatment of insomnia;
- selected agents are used as anticonvulsants, as preoperative sedatives, and to reduce anxiety associated with alcohol withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sedative-Hypnotics: Background Assessment data = Action

A
  • Depression of the CNS
  • Exceptions: Ramelton’s sleep-promoting properties are the result of agonist activity on selective melatonin receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List of Sedative-Hypnotics: Not tested on, but helpful, Heres 3 of the many on that slide

A
  • Temazepam (Restoril)
  • Triazolam (Halcion)
  • Zolpidem (Ambien)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sedative-Hypnotics: contraindicated

A

Allergic, Pregnant, lactation, severe hepatic, cardiac, respiratory, or renal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sedative-Hypnotics: caution

A

Those who are suicidal or who are addicted to drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sedative-Hypnotics: S/E

A
  • Drowsiness & confusion
  • Lethargy
  • tolerance
  • Dependance
  • hypotension
  • Abnormal thinking and behavioral changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ADHD Agents: Action of stimulants

A
  • The CNS stimulants (Amphetamines, methylphenidate) increase levels of norepinephrine, dopamine, and serotonin in the CNS
  • Their effectiveness in the treatment of ADHD is thought to be based on the activation of dopamine D4 receptors, which depress motor activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ADHD Agents: Action of Non-stimulants

A
  • Atomoxetine (straterra) inhibits the reuptake of norepinephrine and bupropion (wellbutrin) blocks the neuronal uptake of serotonin, norep., and dopamine
  • Clonidine and Guanfacine stimulate central alpha-adrenergic receptors in the brain resulting in reduced sympathetic outflow from the CNS.
  • The exact mechanism by which these non-stimulant drugs produce the therapeutic effect in ADHD is unclear
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ADHD Agents: Contraindications of Stimulants

A
  • Allergic to sympathomimetic amines
  • clients with advanced ateriosclerosis
  • cardio disease, hyper tn, hyperthyroidism, glaucoma
  • agitated or hyperexcitablity states, hist of drug abuse
  • MAOIs within 14 days of use, and under 3 yrs old
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ADHD Agents: Contraindications of Atomoxetine and Bupropion

A

Contraindicated in clients with hypersensitivity to the drugs, in lactation, and in concomitant use with or within 2 weeks of using MAOIs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ADHD Agents: Contraindications of Bupropion

A

Seizure disorders, acute MI, bulimia or anorexia nervosa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ADHD Agents: Contraindications of Alpha Agonists

A

allergies to it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ADHD Agents: precautions for stimulants

A
  • Children, tourette’s, anorexia, insomnia,
  • Hist of suicide, homicidal tendencies
  • elderly
  • Prolonged use may result in tolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ADHD Agents: Precautions for Atomoxeline and bupropion

A

urinary retention, hepatic, renal, cardio disease, suicidal clients, pregnant, elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ADHD Agents: Precautions for Alpha agonists

A

Coronary insufficiency, recent MI, cerebrovascular disease, renal/hepatic failure,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ADHD Agents: Many S/E…some to note

A
  • Overstimulation, insomnia
  • palpitations, tachycardia
  • Anorexia, weight loss
  • N/V
  • Sedation or rebound syndrome (alpha agonists)